Market cap
28.16x
Current P/E
29.67x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services.

Similar securities

Based on sector and market capitalization

Report issue